Module 3.2.A and 3.2.R: The Appendices and Regional Information Applicants Overlook

Most attention in Module 3 goes to the drug substance and drug product sections. Yet the appendices in 3.2.A and the regional information in 3.2.R often hold the documents that decide whether a dossier passes validation and avoids early questions, particularly on viral and TSE safety.

What belongs in 3.2.A

  • 3.2.A.1 Facilities and equipment: mainly relevant for biotechnology products, describing the manufacturing areas, equipment and measures against contamination and cross-contamination.
  • 3.2.A.2 Adventitious agents safety evaluation: the assessment of risk from viral and non-viral adventitious agents, covering the source of materials, testing and the capacity of the process to clear or inactivate agents.
  • 3.2.A.3 Excipients: full information on novel excipients, used for the first time in a medicinal product or by a new route, presented in a format comparable to that for the active substance.

TSE compliance

Any material of animal origin used in manufacture, including materials used in cell banks, media or excipients, must be assessed against the EU Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products. Applicants commonly rely on EDQM certificates of suitability for TSE risk, or on a risk assessment supported by supplier documentation. A clear table of every animal-derived material, its source, the tissue used and the supporting evidence avoids a predictable question.

What belongs in 3.2.R for the EU

The regional section collects information that EU authorities expect but that is not part of the harmonised CTD. Typical content includes:

  • the process validation scheme for the finished product, where validation at commercial scale has not yet been completed;
  • information on any medical device component, including the notified body opinion required for integral drug–device combinations;
  • certificates of suitability and other supporting certificates, where these are not presented elsewhere;
  • other region-specific items requested by EU guidance for the product type.

Keep the cross-references clean

Because 3.2.A and 3.2.R are often assembled late, they are prone to mismatches with the main sections, for example a validation scheme that refers to batch sizes no longer registered, or a TSE table that omits a recently added supplier. A final consistency check across Module 3 is worth the time.

How PQRA helps

PQRA prepares and reviews appendices and regional information, including TSE compliance tables, adventitious agent assessments and process validation schemes, as part of a complete Module 3 review.

Contact PQRA to discuss your next dossier.

CATEGORIES:

Uncategorized

Tags:

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *